Denmark set to permanently halt use of AstraZeneca COVID-19 vaccine: Media
Denmark will cease to administer AstraZeneca’s COVID-19 vaccine entirely following its possible link to very rare cases of blood clots, several Danish media outlets reported on Wednesday, citing unnamed sources.
The decision, which removes the shot from Denmark’s vaccination scheme, will delay Denmark’s vaccine roll-out by a few weeks, TV 2 said.
For more coronavirus news, visit our dedicated page.
Danish health authorities will hold a press briefing at 1200 GMT, where they are expected to announce the decision to halt using the vaccine.
The European Union’s drug watchdog said last week it had found a possible link between the vaccine and very rare blood clot cases, but said the risk of dying from COVID-19 was “much greater” than the risk of mortality from rare side effects.
The regulator, however, left it to individual states to make their own risk assessments and decide how administer the vaccine based on local conditions that vary widely across the bloc.
A spate of countries across the world, including France and Germany, have resumed administering the shot to some age groups, mostly those above 50 or 60.
Denmark, a country of 5.8 million people, is in the process of reopening schools, restaurants, shopping malls and cultural activities, after the daily infection rate has slowed to 500-600 a day from several thousand in December.
Danish Health Authority director Soren Brostrom said last month that Denmark “follows a precautionary principle” with regards to the AstraZeneca vaccine.
It was the first country to initially suspend all usage of the vaccine in March over safety concerns and has also put Johnson & Johnson’s vaccine on pause pending further investigations into a possible link to rare blood clot cases.
Almost one million Danes have received their first jabs, 77 percent with Pfizer-BioNTech’s vaccine, 7.8 percent with Moderna’s shot and 15.3 percent with AstraZeneca’s, before it was suspended.
Ireland expects AstraZeneca restrictions to have ‘minimal’ impact on vaccine rollout
Explainer: What is known about COVID-19 vaccines and blood clots?
One US patient dies, another in critical condition after J&J vaccine: Official
Ireland expects AstraZeneca restrictions to have ‘minimal’ impact on vaccine rolloutIrish authorities expect new restrictions on the use of AstraZeneca’s COVID-19 vaccine should have a “fairly minimal” impact on the country’s vaccine ... Coronavirus
Australia reports second case of AstraZeneca blood clot, vaccine rollout steadyAustralia said on Tuesday a second person had been diagnosed with a blood clot after receiving the AstraZeneca Plc vaccine but there had been no rise ... Coronavirus
AstraZeneca says it had positive meeting with European Commission over vaccine rowAstraZeneca had a positive meeting with the European Commission last week, the Anglo-Swedish company said after an Italian newspaper said the group ... Coronavirus
Australia abandons COVID-19 vaccination targets after new advice on AstraZeneca shotsAustralia has abandoned a goal to vaccinate nearly all of its 26 million population by the end of 2021 following advice that people under the age of ... Coronavirus